Nivalis Completes Enrollment in Phase 2 Study of Cystic Fibrosis Therapy
Cystic Fibrosis, News
Nivalis Therapeutics has enrolled the last patient in the larger of two Phase 2 clinical trials evaluating the company’s lead clinical candidate, N91115, for the treatment of cystic fibrosis patients with two faulty copies ... Read more